Comparison of Morphometric Assessment Using Methyl Green Pyronin and AgNOR Staining of Oral Squamous Cell Carcinoma
OSCC
1 other identifier
observational
60
1 country
1
Brief Summary
Oral cancer represents the sixth most common cancer worldwide whilst in Pakistan it ranks the second most common cancer in either gender. Histologically, over 90% of oral cancer lesions are squamous cell carcinomas which are diagnosed on the basis of histopathological analysis. However, proliferation kinetics and nucleolar status are not clearly delineated by routine H\&E examination; thus making use of various proliferation markers imperative for the purpose. Nuclear organizer regions (AgNORs) are associated with proliferative activity and represents as a diagnostic aid in oral malignancies. Similarly, methyl green pyronin (MGP) stain has also been valuable as a complement in routine histopathological studies of several neoplastic entities. Morphometric techniques offer an opportunity to quantify nuclear changes associated with malignancy and may provide an objective basis for grading the tumors. The present study is planned to analyze the morphometric parameters of the MGP stain in oral squamous cell carcinoma, and in their various histological grades, and to assess if the MGP staining parameters could give information on the aggressiveness of the malignant lesions of oral cavity. Sections from thirty cases of squamous cell carcinoma along with thirty cases of normal oral mucosa will be evaluated for methyl green pyronin (MGP) and AgNOR staining. Morphometric analysis of various MGP staining and AgNOR parameters would be performed using micrometer. Statistical analysis of the results will be carried out using SPSS. Quantitative variables will be expressed as mean ± Standard Deviation. Frequencies and percentages will be given for qualitative variables. It is hypothesized that oral squamous cell carcinoma will exhibit significantly higher MGP staining and AgNOR staining parameters than normal mucosa of the oral cavity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jun 2013
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2013
CompletedFirst Submitted
Initial submission to the registry
November 7, 2013
CompletedFirst Posted
Study publicly available on registry
November 20, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2013
CompletedNovember 20, 2013
November 1, 2013
5 months
November 7, 2013
November 13, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Mean values of diameter, area and number of nuclei and nucleoli.
Morphometric parameters including diameter,area and number of nuclei and nucleoli will be determined using AgNOR and Methyl Green Pyronin staining methods.
Within one week of staining of slides
Secondary Outcomes (1)
Association of grading of OSCC in relation to morphometric parameters
Within two weeks of staining of slides
Study Arms (2)
Normal or Control group
Those subjects with normal oral epithelium will be included in this group.
Study Group
Those subjects with oral squamous cell carcinoma will be included in this group.
Eligibility Criteria
Study population comprises of subjects reporting to dental departments of tertiary care hospitals of Lahore district in Pakistan.
You may qualify if:
- Specimens of normal epithelium from healthy adult individuals irrespective of age and without habits that predispose to oral cancer
- Cases of clinically and histologically confirmed primary oral squamous cell carcinoma based on WHO criteria
You may not qualify if:
- Subjects of oral squamous cell carcinoma with any treatment therapy other than surgical excision.
- Subjects having metastatic tumors and tumors other than in the oral cavity
- Subjects having recurrent tumors.
- Subjects of normal or control group with history of risk / predisposing factors for oral cancer.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Post Graduate Medical Institute
Lahore, Punjab Province, 54000, Pakistan
Related Publications (1)
Mohtasham N, Mahdavi-Shahri N, Salehinejad J, Ejtehadi H, Torabi-Parizi M, Ghazi N. Detection of nucleoproteins in squamous cell carcinoma, and dysplastic and normal mucosa in the oral cavity by methyl green-pyronin staining. J Oral Sci. 2010 Jun;52(2):239-43. doi: 10.2334/josnusd.52.239.
PMID: 20587947BACKGROUND
Biospecimen
Oral mucosal biopsy specimens of study participants will be collected.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Muhammad Eyyaz Khaleel, M.Phil
Postgraduate Medical Institute, Lahore
- PRINCIPAL INVESTIGATOR
Ali Raza, B.D.S
Postgraduate Medical Institute, Lahore
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Dr. Ali Raza
Study Record Dates
First Submitted
November 7, 2013
First Posted
November 20, 2013
Study Start
June 1, 2013
Primary Completion
November 1, 2013
Study Completion
December 1, 2013
Last Updated
November 20, 2013
Record last verified: 2013-11